Regroup Mass Notification announced that it is donating access to its powerful mass communication platform to organizations needing to communicate more effectively with large groups of people during Hurricane Irma’s expected landfall. Read more >>
The venture investment arm of General Electric Co. continues to show an interest in Massachusetts companies, this time by participating in a $40 million round of funding into Andover-based Aras Corp. The company’s industrial design software is in line with GE’s long-term vision of an internet-connected manufacturing industry. Read more >>
A startup event is taking place in Halifax next Monday that isn’t really about startups. It’s a showcase for high-growth innovation companies, most with international customers. With luck, the attendees will include the broader business community, as this is the perfect opportunity to witness the potential of the startup community.
Showcase includes Spring Loaded Technology. Read more >>
Video advertising technology company, Pixability plays the middleman between the two by helping brands and agencies choose the best platforms for their campaign needs. But as Chris Bennett, managing director at Pixability explains, handling the relationship between the two has inherent complexities. Read more >>
Kelly Childs, her husband Johnny and son Kirklind all have eye conditions. The severity varies, but all are considered legally blind. But thanks to a device from a company called eSight they will have the ability to see more clearly. Read more >>
Although the search for a concussion pill is merely in the “mouse model” phase, significant strides have been made by researchers. Dr. William Korinek, the CEO of Astrocyte Pharmaceuticals, believes such a pill can arrive as early as 2025. Dr. Kun Ping Lu, a doctor researching a possible medication to destroy compounds that cause brain damage, has a slightly-less optimistic time frame. He believes a possible pill could arrive within the next ten years. Read more >>
The “concussion pill” may be coming soon.
“This is coming in 2025 if all goes well,” Dr. William Korinek, the CEO of Astrocyte Pharmaceuticals, said of a drug that turbocharges the brain’s ability to heal its own damage. Read more >>
Corbus Pharmaceuticals to Host Fireside Chat on Dermatomyositis with Expert Physician and Researcher, Victoria Werth, MDZiad
Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it will host a live video webcast (details below) on Tuesday, September 5, 2017 at 12:00 PM ET to discuss dermatomyositis: the disease, its treatment, and its impact on patients’ lives. Read more >>
Tears of joy run down Cheyenne Field cheeks, for the legally blind 17-year-old from Toronto can now see thanks to eSight on Tuesday August 29, 2017.The new electronic glasses enable the legally blind to actually see. Fields wore them for the first time at Casa Loma in Toronto. Read more >>